MEF2A and Alzheimer disease: In sum, our current study demonstrated that miR-147a-overexpressing ADSCs-derived exosomes repressed inflammatory injury and pathological angiogenesis by targeting VEGFA and MEF2A-TSLP axis to alleviate AD (Fig. 8).